Colom LY, Azcue FM, Pérez GRM, Respa M, Cepero CJ, Quesada W

Language: Spanish
References: 26
Page: 115-124
PDF size: 91.39 Kb.

ABSTRACT

Introduction: at present, scientists are resorting more frequently to nature in order to develop drugs against various illnesses such as cancer. The origin of natural products is diverse and their structure is very complex with the capacity of inhibiting through indirect effect the development of tumors by stimulating the defense mechanisms of the body.
Objective: to evaluate the indirect antitumor action of plant extracts in Erlich ascitic tumor cells.
Methods: a group of 50 NMRI-line mice was interperitoneally pretreated with plant extracts during 5 days. After 48 hours, Erlich ascitic tumor cells were transplanted into the mice. Another control group of mice was pretreated with 0.9 % physiological saline solution; at 48 hours they were also implanted the same tumor cells. The antitumor activity was determined by comparing the control group with the group of mice treated with extracts in terms of tumor implant rejection. The product was considered to be active if it caused 60 % tumor growth inhibition or more.
Results: of the evaluated extracts, 5 obtained more than 60 percent of survival in animals at one of the tested doses, with no signs of tumor after observation during 30 days. It proved that these extracts were active.
Conclusions: it was proved that these 5 extracts could be potential products in stimulating immune response, so they should be further studied in the future.

REFERENCES

1. Valladares Cisneros MG. Las plantas medicinales fuentes de mezclas y compuestos. Hypatia-Revista Científico de Divulgación Científica- Tecnología del

2. Liu EH, Qi LW, Wu Q, Peng YB, Li P. Anticancer agents derived from natural products. Mini Rev Medical Chemical. 2009;13:1547-55.

3. Quiroga M. Los productos naturales como antitumorales. Monografías; 2004. Disponible en: http://www.monografias.com/trabajos16/productos-naturalesantitumorales/ productos-naturales-antitumorales.shtmlo

4. Gonzaga ML, Bezerra DP, Alves AP, de Alencar NM, Mesquita R de O, Lima MW et. al. In vivo growth-inhibition of Sarcoma 180 by an alpha-(1—>4)-glucan-beta- (1—>6)-glucan -protein complex polysaccharide obtained from Agaricus blazei Murill. J Nat Med. 2009;63(1):32-40.

5. Gurgel AP, da Silva JG, Grangeiro AR, Oliveira DC, Lima CM, da Silva AC, et al. In vivo study of the anti-inflammatory and antitumor activities of leaves from Plectranthus amboinicus (Lour) Spreng (Lamiaceae). J Ethnopharmacol. 2009;125(2):361-3.

6. Fidler IJ, Berendt M, Oldham RK. The rationale for and desing of a screening procedure for the assessment of biological response modifiers for cancer treatment. J Biol Resp Modif. 1982;1:15-26.

7. Benny KH, Tan. J. Vanitha. Immunomodulatory and antimicrobial effects of some traditional chinese medicinal herbs. A Review. Current Medicinal Chemistry. 2004;11:1423-30.

8. Kanestski RG. Interacción del tumor y el organismo. Kiev: Naukova Dunska;1977.

9. Lage A. Evolución y estado actual de programa de tamizaje. Rev Cubana Oncol. 1985;1(2):164-75.

10. Yun-Hee S, Kyung-Soo N. Antimutagenicity and induction of anticarcinogenic phase II enzymes by basidiomicetes. J Ethnopharmacol. 2001;77:103-9.

11. Pérez RP, Ávila AD, Edgill R, Colom Y, Quesada W, Bello JL, et al. Actividad antitumoral de una mezcla de polisacáridos obtenida de la especie Argemone mexicana L. Rev Cubana Plant Med. 2005;10(3-4).

12. Bello JL, Pereda CM, Silva JP, Mainardi JV, Fernández LE. Influencia del tratamiento con polisacáridos de origen marino sobre el prendimiento del tumor ascítico de Ehrlich. Rev Cubana Oncol. 1985;1:200-7.

13. Bello JL. Estudio antitumoral indirecto. Rev Cubana Oncol. 1991;7(1):34-3.

14. Pereda CM. Actividad biológica de biopolímeros de origen marino. Influencia sobre la actividad de macrófagos provenientes de ratón. Rev Cubana Oncol. 1990;6(2):270-1.

15. Pereda CM. Actividad biológica de biopolímeros de origen marino. Influencia sobre la actividad asesina NK en el ratón. Rev Cubana Oncol. 1990;6(2):265-9.

16. Pereda CM. Actividad biológica de biopolímeros de origen marino. Influencia sobre la metastización pulmonar. Rev Cubana Oncol. 1990;6(2):275-80.

17. Itoh H. Antitumor activity and immunological properties of marine algae polysaccharides. Anticancer Research. 1993;13:475-80.

18. Song JV, Yang HO, Pyo SN, Jung IS. Inmunomodulatory activity of proteinbound polisaccaharide extracted from Chelidonium majus. Arch Pharmacology Research. 2002;25(2):158-64.

19. Pandey R, Maurya R, Singh G, Sathiamoorthy B, Naik S. Inmunosupressive properties of flavonoids isolated from Boerhaavia diffusa Linn. Int Inmunopharmacol. 2005;5(3):541-53.

20. Colom Y, Azcue M, Pérez R, Respall M, Ruiz R, Quesada W. Evaluación antitumoral de extractos de plantas de la flora cubana en el tumor experimental leucemia linfocítica P388. Rev Cubana Plant Med. 2005;10(2).

21. Ito H, Hidaka H, Sugiura M. Effects of Coriolan, an antitumor polysaccharide, produced by Coriolus versicolor. Iwade Jap J Pharmacol. 1979;29:953-7.

22. Fidler I, Berendt M, Oldham RK. The nationale from design of screening procedure for assessment of biological response modifiers for cancer treatment. J Biological Response Modifiers. 1982;1(1).

23. Mizuno T, Ohsawa K, Hagiwara N, Kuboyama R. Fractionation and characterization of antitumor polysaccharides from Maitake, Grifola frondosa. Agric Biol Chem. 1986;50:1679-88.

24. Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F. Inhibition of mouse sarcoma-180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature (Lond). 1969;222:687-8.

25. Furue H, Itoh I, Kimura T. Phase III study on Lentinan. Jap J Cáncer Chemother. 1981;8:944-82.

26. Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh T, et al. Endpoint results of phase III study of Lentinan. Jap J Cáncer Chemother. 1985;12:366-80.